A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors.

Volume: 3, Issue: 4, Pages: 215 - 223
Published: Dec 1, 2014
Abstract
A critical requirement in neuroendocrine tumor (NET) management is a blood biomarker test that is sensitive, specific and reproducible. We evaluated a PCR-based 51-transcript signature to detect tumors, compared it with chromogranin A (CgA) and examined the confounding effect of proton pump inhibitors (PPIs), which cause falsely elevated CgA levels. The multigene signature was evaluated in two groups. Group 1: 125 prospectively collected NETs:...
Paper Details
Title
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors.
Published Date
Dec 1, 2014
Volume
3
Issue
4
Pages
215 - 223
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.